Home/Filings/4/0001493152-22-009481
4//SEC Filing

Dexter Susan 4

Accession 0001493152-22-009481

CIK 0001106838other

Filed

Apr 7, 8:00 PM ET

Accepted

Apr 8, 4:30 PM ET

Size

5.0 KB

Accession

0001493152-22-009481

Insider Transaction Report

Form 4
Period: 2021-12-15
Dexter Susan
Chief Technical Officer
Transactions
  • Award

    Common Stock

    2021-12-15+63,104126,572 total
Footnotes (1)
  • [F1]On December 15, 2021, the Reporting Person was granted 63,104 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.

Documents

1 file

Issuer

Sonnet BioTherapeutics Holdings, Inc.

CIK 0001106838

Entity typeother

Related Parties

1
  • filerCIK 0001806764

Filing Metadata

Form type
4
Filed
Apr 7, 8:00 PM ET
Accepted
Apr 8, 4:30 PM ET
Size
5.0 KB